Marked hemiatrophy in carriers of Duchenne muscular dystrophy.
Détails
Télécharger: BIB_312A8E4A77EA.P001.pdf (450.91 [Ko])
Etat: Public
Version: Final published version
Etat: Public
Version: Final published version
ID Serval
serval:BIB_312A8E4A77EA
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Etude de cas (case report): rapporte une observation et la commente brièvement.
Collection
Publications
Institution
Titre
Marked hemiatrophy in carriers of Duchenne muscular dystrophy.
Périodique
Archives of Neurology
ISSN
1538-3687 (Electronic)
ISSN-L
0003-9942
Statut éditorial
Publié
Date de publication
2010
Peer-reviewed
Oui
Volume
67
Numéro
4
Pages
497-500
Langue
anglais
Notes
Publication types: Case Reports ; Journal Article ; Research Support, Non-U.S. Gov't Publication Status: ppublish
Résumé
OBJECTIVE: To describe the clinical and molecular genetic findings in 2 carriers of Duchenne muscular dystrophy (DMD) who exhibited marked hemiatrophy. Duchenne muscular dystrophy is an X-linked disorder in which affected male patients harbor mutations in the dystrophin gene. Female patients with heterozygous mutations may be manifesting carriers.
DESIGN: Case study.
SETTING: Neurology clinic.
PATIENTS: Two manifesting carriers of DMD.
INTERVENTIONS: Clinical and radiologic examinations along with histologic and molecular investigations.
RESULTS: Both patients had marked right-sided hemiatrophy on examination with radiologic evidence of muscle atrophy and fatty replacement on the affected side. In each case, histologic analysis revealed a reduction in dystrophin staining on the right side. Genetic analysis of the dystrophin gene revealed a tandem exonic duplication in patient 1 and a multiexonic deletion in patient 2 with no further point mutations identified on the other chromosome.
CONCLUSIONS: Marked hemiatrophy can occur in DMD manifesting carriers. This is likely to result from a combination of skewed X-inactivation and somatic mosaicism.
DESIGN: Case study.
SETTING: Neurology clinic.
PATIENTS: Two manifesting carriers of DMD.
INTERVENTIONS: Clinical and radiologic examinations along with histologic and molecular investigations.
RESULTS: Both patients had marked right-sided hemiatrophy on examination with radiologic evidence of muscle atrophy and fatty replacement on the affected side. In each case, histologic analysis revealed a reduction in dystrophin staining on the right side. Genetic analysis of the dystrophin gene revealed a tandem exonic duplication in patient 1 and a multiexonic deletion in patient 2 with no further point mutations identified on the other chromosome.
CONCLUSIONS: Marked hemiatrophy can occur in DMD manifesting carriers. This is likely to result from a combination of skewed X-inactivation and somatic mosaicism.
Mots-clé
Adult, Arm/pathology, Arm/physiopathology, DNA Mutational Analysis, Dystrophin/genetics, Exons/genetics, Female, Functional Laterality/physiology, Genetic Diseases, X-Linked/genetics, Genetic Diseases, X-Linked/pathology, Genetic Predisposition to Disease, Genetic Testing, Genotype, Heterozygote, Humans, Leg/pathology, Leg/physiopathology, Magnetic Resonance Imaging, Middle Aged, Mosaicism, Muscle, Skeletal/pathology, Muscle, Skeletal/physiopathology, Muscular Atrophy/genetics, Muscular Atrophy/pathology, Muscular Dystrophy, Duchenne/genetics, Mutation/genetics, X Chromosome Inactivation/genetics
Pubmed
Web of science
Création de la notice
27/04/2010 15:17
Dernière modification de la notice
20/08/2019 13:16